Kathmere Capital Management LLC Has $449,000 Stake in Haleon plc (NYSE:HLN)

Kathmere Capital Management LLC boosted its holdings in shares of Haleon plc (NYSE:HLN) by 131.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 47,099 shares of the company’s stock after buying an additional 26,744 shares during the quarter. Kathmere Capital Management LLC’s holdings in Haleon were worth $449,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HLN. Fortitude Family Office LLC bought a new position in Haleon during the third quarter valued at about $28,000. Versant Capital Management Inc grew its stake in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after buying an additional 3,348 shares during the last quarter. Toronto Dominion Bank grew its position in Haleon by 3,470.0% during the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in Haleon during the 3rd quarter worth about $57,000. Finally, BOKF NA raised its position in shares of Haleon by 68.8% during the second quarter. BOKF NA now owns 6,972 shares of the company’s stock worth $58,000 after acquiring an additional 2,842 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. UBS Group upgraded shares of Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Finally, Sanford C. Bernstein downgraded Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Haleon currently has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Trading Up 1.2 %

Shares of HLN stock opened at $9.12 on Thursday. The stock has a market cap of $41.28 billion, a P/E ratio of 26.82, a price-to-earnings-growth ratio of 2.95 and a beta of 0.29. Haleon plc has a 1 year low of $7.89 and a 1 year high of $10.80. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a 50 day simple moving average of $9.56 and a 200 day simple moving average of $9.69.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.